![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
In vitro Assessment of Drug-Drug Interaction Potential of Boceprevir As an Inhibitor and Inducer of Drug Metabolizing Enzymes and Transporters
|
|
|
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
Xiaoyan Chu, Xiaoxin Cai, Dan Cui, Raymond Evers, Mitchell D Green, Anima Ghosal, Cuyue Tang, Yuhsin Kuo, Yuexia Liang, Cheri M Maciolek,Jairam Palamanda, Grace Chan, Jocelyn Yabut, Thomayant Prueksaritanont Merck, Whitehouse Station, NJ USA
AASLD: Concomitant Medication Use (drug interactions) in Patients with Hepatitis C Genotype 1 Treated with Boceprevir Combination Therapy - (11/15/11)
![AASLD1.gif](../images/111611/111611-4/AASLD1.gif)
![AASLD2.gif](../images/111611/111611-4/AASLD2.gif)
![AASLD3.gif](../images/111611/111611-4/AASLD3.gif)
![AASLD4.gif](../images/111611/111611-4/AASLD4.gif)
![AASLD5.gif](../images/111611/111611-4/AASLD5.gif)
![AASLD6.gif](../images/111611/111611-4/AASLD6.gif)
![AASLD7.gif](../images/111611/111611-4/AASLD7.gif)
![AASLD8.gif](../images/111611/111611-4/AASLD8.gif)
![AASLD9.gif](../images/111611/111611-4/AASLD9.gif)
![AASLD10.gif](../images/111611/111611-4/AASLD10.gif)
![AASLD11.gif](../images/111611/111611-4/AASLD11.gif)
![AASLD12.gif](../images/111611/111611-4/AASLD12.gif)
![AASLD13.gif](../images/111611/111611-4/AASLD13.gif)
![AASLD14.gif](../images/111611/111611-4/AASLD14.gif)
![AASLD15.gif](../images/111611/111611-4/AASLD15.gif)
![AASLD16.gif](../images/111611/111611-4/AASLD16.gif)
![AASLD17.gif](../images/111611/111611-4/AASLD17.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|